Where are the 1 cent updates? Get back to work Sport!

Or are we only doing 25 cent updates now?

It was a good fireside chat.

McNally was less robotic than usual, and his excitement and confidence in the product came through well. 20 engineers working on on ENOS and Medtronic milestones. No more outsourcing.

Monique Delorme excellent as well, for the short time she spoke.

They are very excited about having full funding until FDA, and the interest from investors to participate in offerings was described as "insatiable" in the last few months. They obviously could easily raise a lot more, but don't have to anymore.

Clear path forward....

Don’t forget how deep in the toilet we were. Obviously there is a price to pay, but a much better one than a fire sale. 2 billion and up is my guess...not a napkin, more like a handshake...

I think so....

...the whole setup feels like Enos piggybacking on the movement of MDT/Hugo, and it works best for both for them.

In reality, I believe ENOS is already ready for an IDE application, but it's not necessarily the best thing for both companies to do that before Hugo.

In other words, there is no real delay on the part of TMDI. No doubt they'll use the extra time they have for whatever improvements, but there's nothing justifiable in the way to not apply already, or at least very soon (nothing like the year we have been told).

When exactly a BO happens is anyone's guess, but if you want to know the timeline of TMDI, you have to watch the timeline of MDT.

Next milestones likely have nothing to with ENOS, but more likely with patent applications into Hugo, although they might be presented differently in very vague terms.

The deal is to make Hugo happen, and ENOS soon after....

https://finance.zacks.com/stock-buyout-offer-8911.html

Bought some more in the dip Friday, probably my last given that accumulation seems to have started in earnest, and once the rumors start for real, it's too late.

Could be a good day!

The nice thing about this run is that it appears (to me) to be based on an increased awareness among investors that a buy-out is in the cards, not too far away, and that they actually believe it this time. That shift can go a very long way in terms of PPS...as we have seen with TRIXIE and its run to 1 billion MC which unlike TMDI was based on nothing. So we might be seeing the beginning of an alignment of PPS with facts finally, which is very good news.

TRXC not sharing in the fun this time, like last time. This is eom only...whatever is coming...

And it looks that is happening for now. Could be a nice ABCD if we get well past .82 in the course of the day.

Agree it should follow soon after instrument testing. There's also independent lab testing for the equipment for as per the original previous milestones, but that does not have to take long. I forgot what they called these tests, but it was essentially to make sure no-one on the operating table, or around it, electrocutes themselves. It's a robot after all working in a wet environment.

Me too! All the birds are after me now!

And that was with a 500 million cheque...no public raises required.

But Titan is not a top 1000 company.

Yes, it passed my mind, and it may or may not suppress a buyout price. But, the requirement in the agreement for Titan to raise the funding (which they just did) seems to indicate that Medtronics wants a finished product. So yes, it's a concern, but not as dire as feared.

I made my first buy there in 2014...75 pre-RS..."outch"...

Since then, Titan has been like savings account from hell with -25% interest rates.

But, cost basis at 2.5 now, and there's hope finally.

Good post. I remember I was fascinated by this a few years ago looking into the mechanism that Medtronic used with Mazor, just to see what might happen to Titan in a similar scenario with whomever.

Because of this, and everything that happened recently, I have no doubt this is what the plan is for Titan as well. Gave me the confidence I needed to buy more. It's exactly how Medtronic operates, with a few changes adapted to Titan.

It's also why the billion dollar talk is not premature anymore. I realize it feels like that for some of the newer people, happy with a quick 100% profit, but longs here have always been it for more than that from the beginning. With some evidence now that this is happening, that is real foresight to some degree...(while having suffered terribly from too early foresight in the process)

It's even more bullish in Titan's case, since if I remember correctly, they got involved with Mazor when they were already selling. Huge vote of confidence in SPORT so early in the game (as well as their lack of confidence in Hugo most likely).

Flat today as far as PPS, which always seem to happen shortly before finalizing the raise. Maybe news after the bell, and we're off to the races...

Always going to be points of selling pressure as it moves up, profit taking, people moving out, etc.... an upwards zig saw pattern far better and more sustainable, so I would not worry.

testing support 1.5 ...good sign especially if holds...and then up again!

Yes, it's nice. Maybe we see some more old-timers coming back. Hope ORrep held to this position.

Sport, good riddance...

Long term investor since 2014. Only found out about this Saturday, not following these boards already for a while. But, bought a bunch this morning further lowering my cost basis this morning at 1.

It's a no-brainer. Fun times!

Looks like it's again spiking just now...

I'm just here to watch Sport go apeshit...

Oh Sport..you hear that? There's hope yet

Looks like you lost money

I don't think any positive comment will be well-received, given it could easily all go to hell.

But if you want something mildly positive here it is:

1) The relationship with the primary developer is shaky, but still intact (having to replace the primary developer would likely not be feasible).
2) The problem is not software or hardware design perse, but the interface between instruments and camera system with the robot.
3) The secondary supplier who makes "devices" (instruments?) according the prospectus seems replaceable if needed.
4) It seems this secondary supplier is has messed things up big time for us, although it does not absolve Titan management either. They should have been on top of it, and made changes earlier even if meant a delay. It's a serious miscalculation, probably in part due to doing too much at once, but market perception could shift...
5) Titan likely playing legal hardball with that supplier as they should, but it means total silence for us...
6)PPS might recover if current funding round is successful.

As to the fact there may not be any funding, and the fact there are more to come, yeah, I got nothing...except fire sale and get a few bucks per share.

Probably wise. Selling does not make much sense right now, since what's the difference anyhow at this point. However, I imagine some people just want to want to stop puking, and leave it all behind emotionally. Good enough reason as well I guess....

Yup...and off it went to 4.50 in one month at that time..more reason to go higher now..

Nothing we have not seen before. Fundamentals have not changed, only improved...so nothing to see here...and move on...

Chicken or egg...you're all still crazy.

Highlights M&A

1) New Q1 2020 milestone - a) Ongoing software development and implementation and b) Planning and preparation for manufacturing and commercialization. Cost 8 million.
2) The Company had $23,610,440 of cash and cash equivalents on hand. No mention of how far current cash will take us.
3) the Company believes that it will need to raise approximately $35 million to fund it operations to the end of the first quarter of 2020.
4) The company will continue to explore alternative sources in order to minimize dilutive effects, including strategic partnerships, private placements and debt.
5) The Company recently updated its Milestone table with the expectation that the submittal of its IDE application to the FDA would take place early during the third quarter 2019 following successful completion of prerequisite animal and cadaver studies during the second quarter.
6) The recruitment of surgeons from multiple hospital sites has been initiated and will be necessary to perform the surgeries. Each of these sites will require approval of their independent Institutional Review Board (“IRB”) to approve the studies.
7) During the second and third quarters of 2019, the Company expects to complete the recruitment of surgeons and hospitals for the studies, secure IDE approval by the FDA and approvals by the IRB of each hospital, in preparation for the confirmatory human studies planned for completion during the fourth quarter.

I would. Perhaps they'll be able to rebrand SPORT19. He needs a good overhaul.

I don't think the rebranding is much of a "thing", also not in terms of getting PPS to move.

Going back historically, what got PSS to move big were the pre-clinical studies from 3$ to 15$ (.10 to .50 back then).

Given that history is generally the best predictor, I suspect that is what the market looking for now, and that excellent surgeon feedback on the improved SPORT with the animal and cadaver studies taking place this quarter will make it move.

In other words, did the system overcome the limitations of the previous prototype (esp. issues with insertion, camera range of motion, and lens cleaning), and how much better is the new system in other respects we don't even yet know about?

Personally, I like this scenario far better, than hoping for something fluffy like rebranding to move the needle. It goes straight to the core of the issue. Does the machine work as intended and will it sell well once approved?

This is wall street after all...money talks...

I don't expect us to go to 15 like the last time, because excellent reviews will be more baked-in than the last time, but I think it will count for something...

I do also still expect a belated reaction to the design freeze over time. Shorts have pounded on this stock, and there's still a lot resistance. But there's no reason we won't climb back to the recent highs of 4.50 once we're past that.

Could be just renaming the product, or perhaps even a company name change. Titan medical does sound rather stodgy.

They're averaging down like the rest of us! lol

But agree, not a big deal...

Well, the ask is 41.10 right now. Not that it will remain that way, but never seen it so high in off trading hrs.

fake news...

I was expecting to hear some more details on the midgetstick....how disappointing..

https://money.usnews.com/investing/stocks/stocks-under-10

*yawn*

Serafino will be more than worth it once we get closer to commercialization through Longitude Capital, which have previously funded his enterprises....

http://www.longitudecapital.com/

Same guy, name at least...

Nice close again today though, not like the slide from the last time so far, so we're looking good. Would be nice to have those sleazy, disingenuous posts from our resident short disappear soon.

catfight...!

Yes, it will raise PPS. Important to remember that there was no design freeze ahead of promising pre-clinical studies end of 2018, yet the stock climbed till 15$, but this was squashed with the delay.

This time, with a design freeze, is a much clearer message to the market that there not only will not be a delay, but also likely even better pre-clinical results with improvements.

The first pre-clinical studies will immediately follow design freeze. So it stands to reason that we will climb into that range 10-15 fairly quickly (by the fall) following an initial bump in PPS with design freeze (early summer). My guess is 6-8 early summer.

We'd want that to happen, to have the 40 million in warrants for Q3 and Q4, and a bit beyond. Otherwise, yet another financing (but it is becoming less and less relevant). Things are pretty bright at this point as is.

End of year, anything is possible with successful human trials and FDA submission as far as PPS. That will give us some wild press...tummies with no scars....road shows as we wait for FDA approval...and some real initial serious interest from acquirers..